ClinicalTrials

Ivermectin's Unfulfilled Promise: A Potential Cancer Drug Quashed

The Quiet Conversation: Unpacking Medications and Your Brain's Future

A Renewed Sense of Hope: Roche's Ocrevus Continues to Impress in MS Care

A New Frontier in Cancer Treatment: The Promise of mRNA Vaccines

The Quest for Hair: Nektar's Rezpeg Promises a New Dawn for Alopecia Sufferers

A Glimmer of Hope: New Experimental Treatment Offers Breakthrough for Pancreatic Cancer Patients

Cannabis's Untapped Potential: Why Medical Research Is Lagging Behind the Green Rush

A Luminary's Farewell: Remembering Dr. Iris Long

A Game Changer? Allogene's 'Off-the-Shelf' CAR T Therapy Shows Stunning Promise in B-Cell Lymphoma

The Unraveling of Kezar Life Sciences: How an FDA Delay Triggered a Biotech Startup's Collapse

Jasper Therapeutics Forges Ahead: A Deep Dive into 2025 Results and Future Horizons for Briquilimab

Inspira Technologies' Transformative 2025: Unpacking a Year of Strategic Growth and Innovation

Quoin Pharmaceuticals Unveils Significant Clinical Progress and Strong Financial Standing for 2025

Unpacking Newron's Q4 2023: A Closer Look at Evenamide's Journey and Financial Health

Unlocking the Brain's Mysteries: Denali Therapeutics' Bold Quest Against Neurodegenerative Disease

A Deeper Look at Assembly Biosciences' Latest Financial Journey

Assembly Biosciences Navigates 2025: A Deep Dive into Financial Strategy and Groundbreaking Clinical Advances

Pelthos Therapeutics Unveils 2025 Financials, Charting Course for Future Innovations

A Glimmer of Hope: Beyond Cancer's Early Clinical Results Spark Optimism

uniQure Soars: Mizuho Upgrade Rekindles Hope for Huntington's Gene Therapy

Engene Holdings: Why 2026 Could Be Their Pivotal Moment

ImmunityBio's Stock Plunge: Can Dr. Soon-Shiong's Cancer Science Convince Skeptical Investors?

A New Dawn in Pain Relief: Vertex Pharmaceuticals' Breakthrough Soars Stock

A Stinging Setback: Incyte's Cancer Therapy Fails to Clear FDA's High Bar

A Nuanced Look at Helus Pharma's HLP004 for Anxiety: Beyond the Primary Endpoint

Teva Secures Landmark $400 Million Investment from Blackstone for Pivotal Respiratory Drug

Celldex Therapeutics Soars: Is a Game-Changing Skin Treatment on the Horizon?

Taro Pharmaceuticals: A Bladder Cancer Setback Sparks a 15% After-Hours Slide – Is This a Buy-the-Dip Moment or a Sign of Deeper Trouble?

The AI Revolution: Reshaping How We Develop Life-Saving Drugs

The Silent Guardians: Unpacking the FDA's Vital Role in Drug Study Integrity

Unveiling the Truth: Are FDA Drug Studies Truly Robust?

Under the Microscope: Reassessing the Foundations of Our Medicines

Palatin's Latest Quarter: Vyleesi Surges, Key Drug Trials Advance, and a Glimpse into the Future

Sana Biotechnology: A Deep Dive into a Speculative Biotech Bet

Viking Therapeutics Rockets Skyward: Is Their Obesity Drug the Next Market Game-Changer?

The Keto Diet and Schizophrenia: Can It Truly "Cure" or Just Help?

Veradermics Steps Onto the Public Stage: A Deep Dive into Their $200 Million IPO Bet

Navigating Choppy Waters: Three Healthcare Stocks Facing Significant Headwinds This Quarter

Summit Therapeutics on the Cusp: A Dual-Action Lung Cancer Drug Faces its Moment of Truth